B700 antigen as a component of an antimelanoma vaccine: formalinized extracellular antigens.

Pigment Cell Res

Department of Experimental Pathology, Roger Williams Medical Center, Brown University, Providence 02908.

Published: September 1992

Formalin fixation has enjoyed widespread use in the preparation of antibacterial and other vaccines, but rather less use in antitumor vaccines. Previous studies from our laboratories have demonstrated the efficacy of antimelanoma vaccines in mice, produced from formalinized antigens shed by cultured melanoma cells. In this study, we provide evidence that the immunodominant component of that vaccine is the well-characterized B700 melanoma antigen.

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1600-0749.1992.tb00006.xDOI Listing

Publication Analysis

Top Keywords

b700 antigen
4
antigen component
4
component antimelanoma
4
antimelanoma vaccine
4
vaccine formalinized
4
formalinized extracellular
4
extracellular antigens
4
antigens formalin
4
formalin fixation
4
fixation enjoyed
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!